Smart FL: meta-learning for federated blood marrow smear classification - Report - MDSpire

Smart FL: meta-learning for federated blood marrow smear classification

  • By

  • N. Ilakiyaselvan

  • Srivastava Sanskar

  • D. Aarthi

  • V. Kalyanasundaram

  • July 9, 2026

  • 0 min

Share

Clinical Report: Federated Learning with Meta-Learning for Enhanced Classification of Bone Marrow Smears

Overview

This study presents a novel approach utilizing federated learning and meta-learning to improve the classification accuracy of bone marrow smears, particularly in classes with limited sample sizes. The proposed method achieved an accuracy of 96 ± 1% in these challenging classes.

Background

Accurate classification of bone marrow cells is essential for diagnosing hematological disorders such as leukemia and lymphoma. Traditional methods rely heavily on expert analysis, which can be time-consuming and subject to human error. The integration of machine learning techniques presents an opportunity to enhance diagnostic accuracy.

Data Highlights

No numerical data or trial data presented in the source material.

Key Findings

  • The study introduces a federated learning framework to address data privacy concerns in medical datasets.
  • Meta-learning is employed to enhance model adaptability and performance across diverse patient populations.
  • The approach achieved an accuracy of 96 ± 1% in classes with low sample sizes.
  • Utilizing a ResNet-18 backbone, the method improves generalization capabilities of models in clinical settings.

Clinical Implications

The proposed federated learning approach allows for improved classification of bone marrow smears while maintaining patient data confidentiality.

Conclusion

The integration of federated learning and meta-learning addresses critical challenges in data privacy and scarcity.

Related Resources & Content

  1. Frontiers in Medicine, 2026 -- Automated bone marrow cell classification using ensemble learning: performance, generalization, and clinical interpretability
  2. Frontiers in Immunology, 2026 -- Cross-modal fusion of cytomorphology and 18F-FDG PET/CT for non-invasive bone marrow immune microenvironment decoding in multiple myeloma
  3. Frontiers in Oncology, 2026 -- Hybrid handcrafted and deep feature fusion for automated acute myeloid leukemia classification using TCMA-Net on a class-balanced dataset
  4. asco ai in oncology, 2026 -- Federated Learning Enables Robust Prognostic Modeling in Anal Cancer Across International Real-World Cohorts
  5. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms | Leukemia
  6. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel | Blood | American Society of Hematology
  7. Artificial Intelligence in Software as a Medical Device | FDA
  8. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms | Leukemia
  9. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel | Blood | American Society of Hematology
  10. Artificial Intelligence in Software as a Medical Device | FDA

Original Source(s)

Related Content